There was a significant difference in the baseline BMI between the two groups, with the acetazolamide group having a mean BMI of 32, compared with 38 in the GLP-1 agonist group
Increased serum levels of human pancreatic polypeptide (HPP), gastrin, motilin, CCK, PYY, ghrelin, and also GIP, GLP-1, and GLP-2 have been reported either at baseline or postprandially in UC and/or CD (154, 163, 165168)
If you have concerns about the decision, seeking a second opinion from another qualified provider is reasonable and often helpful
You should NOT use tirzepatide if you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, severe gastrointestinal disease, or if you are pregnant, planning to become pregnant, or breastfeeding
Understanding these changes helps contextualize your progress beyond simple weight measurement
Progress photos and weight tracking Your progress is more than a number on the scale